215 related articles for article (PubMed ID: 2989677)
21. Second meeting of the WHO Collaborating Centres on AIDS: Memorandum from a WHO meeting.
Bull World Health Organ; 1986; 64(1):37-46. PubMed ID: 3015444
[TBL] [Abstract][Full Text] [Related]
22. Acquired immunodeficiency syndrome: meeting of the WHO Collaborating Centres on AIDS.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1985 Nov; 34(44):678-9. PubMed ID: 3932833
[TBL] [Abstract][Full Text] [Related]
23. Human T-lymphotropic virus type III/lymphadenopathy-associated virus antibody testing at alternate sites.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1986 May; 35(17):284-7. PubMed ID: 3010070
[TBL] [Abstract][Full Text] [Related]
24. Virologic studies of HTLV-III/LAV in pregnancy: case report of a woman with AIDS.
Rogers MF; Ewing EP; Warfield D; Hardy AM; Emery DR; Wolf GC
Obstet Gynecol; 1986 Sep; 68(3 Suppl):2S-6S. PubMed ID: 3016628
[TBL] [Abstract][Full Text] [Related]
25. Unique pattern of HTLV-III (AIDS-related) antigen recognition by sera from African children in Uganda (1972).
Saxinger C; Levine PH; Dean A; Lange-Wantzin G; Gallo R
Cancer Res; 1985 Sep; 45(9 Suppl):4624s-4626s. PubMed ID: 2990697
[TBL] [Abstract][Full Text] [Related]
26. Tuberculosis--United States, 1985--and the possible impact of human T-lymphotropic virus type III/lymphadenopathy-associated virus infection.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1986 Feb; 35(5):74-6. PubMed ID: 3080659
[TBL] [Abstract][Full Text] [Related]
27. A classification of HTLV-III infection based on 75 cases seen in a suburban community.
Kaplan MH; Pahwa SG; Popovic M; Sarngadharan MG; Gallo RC
Cancer Res; 1985 Sep; 45(9 Suppl):4655s-4658s. PubMed ID: 2990703
[TBL] [Abstract][Full Text] [Related]
28. Opportunistic malignancies and the acquired immunodeficiency syndrome.
Mueller N; Hatzakis A
Princess Takamatsu Symp; 1987; 18():159-71. PubMed ID: 3506539
[TBL] [Abstract][Full Text] [Related]
29. Impact of the expanded AIDS surveillance case definition on AIDS case reporting--United States, first quarter, 1993.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1993 Apr; 42(16):308-10. PubMed ID: 8474424
[TBL] [Abstract][Full Text] [Related]
30. Update: Public Health Service workshop on human T-lymphotropic virus type III antibody testing--United States.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1985 Aug; 34(31):477-8. PubMed ID: 2991728
[TBL] [Abstract][Full Text] [Related]
31. The Vancouver Lymphadenopathy-AIDS Study: 4. Effects of exposure factors, cofactors and HTLV-III seropositivity on number of helper T cells.
Schechter MT; Boyko WJ; Jeffries E; Willoughby B; Nitz R; Constance P; Weaver M; Wiggs B; O'Shaughnessy M
Can Med Assoc J; 1985 Aug; 133(4):286-92. PubMed ID: 2990652
[TBL] [Abstract][Full Text] [Related]
32. HTLV and immunosuppression.
Essex M; Kanki P; Allan J; Barin F; McLane MF; Lee TH; Kitchen L; Homma T; Malone G; Yokota T
Princess Takamatsu Symp; 1984; 15():309-18. PubMed ID: 6100649
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.
Yarchoan R; Redfield RR; Broder S
J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028
[TBL] [Abstract][Full Text] [Related]
34. HTLV: epidemiology and relationship to disease.
Blattner WA; Clark JW; Gibbs WN; Williams CK; Nomura A; Mann D; Saxinger C; Robert-Guroff M; Gallo RC
Princess Takamatsu Symp; 1984; 15():93-108. PubMed ID: 6100653
[TBL] [Abstract][Full Text] [Related]
35. HTLV-3 infection and AIDS: risk of spread by heterosexual contact.
Craske J
IPPF Med Bull; 1986 Feb; 20(1):3-4. PubMed ID: 12267664
[TBL] [Abstract][Full Text] [Related]
36. Assessment of screening as a preventive technology: the example of HTLV-III/LAV antibody testing.
Ory HW; Koplan JP; Allen JR
Isr J Med Sci; 1986; 22(7-8):524-8. PubMed ID: 3640749
[TBL] [Abstract][Full Text] [Related]
37. The AIDS epidemic.
Landesman SH; Ginzburg HM; Weiss SH
N Engl J Med; 1985 Feb; 312(8):521-5. PubMed ID: 2982097
[TBL] [Abstract][Full Text] [Related]
38. Leads from the MMWR. Revision of case definition of acquired immunodeficiency syndrome for national reporting--United States.
JAMA; 1985 Aug; 254(5):599-600. PubMed ID: 2989566
[No Abstract] [Full Text] [Related]
39. [HTLV-III infections and AIDS--current epidemiology and serology].
Biberfeld G; Böttiger M; Biberfeld P
Lakartidningen; 1985 May; 82(20):1867-70. PubMed ID: 2987632
[No Abstract] [Full Text] [Related]
40. HTLV-III serology distinguishes atypical and endemic Kaposi's sarcoma in Africa.
Bayley AC; Downing RG; Cheingsong-Popov R; Tedder RS; Dalgleish AG; Weiss RA
Lancet; 1985 Feb; 1(8425):359-61. PubMed ID: 2857417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
